CF PharmTech, Inc. (SEHK: 2652)
Health Care · Pharmaceuticals · CN
HK$16.90
-1.80% today · -56.1% 1Y
CF PharmTech, Inc. (SEHK: 2652) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $884.22M and employs 540 people.
Over the last twelve months the share price has lost 56.1%, trading between 14.82 and 48.80.
Tweenvest scores CF PharmTech, Inc. across four factors: growth 100/100. Its strongest factor is growth.
2652 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $884.22M
- Revenue (TTM)
- $61.84M
- P/E
- —
- EPS
- 0.01
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$48.80
- 52-week low
- HK$14.82
- Avg volume (3M)
- —
- Shares outstanding
- 410.58M
- Employees
- 540
- Next earnings
- —
About CF PharmTech, Inc.
CF PharmTech, Inc. engages in research and development, production, and sale of respiratory drugs and other related medical products in China. It offers Shufeimin, an azelastine hydrochloride and fluticasone propionate nasal spray; ChangQi, a budesonide inhalation suspension solution; ChangShu, a salbutamol sulfate inhalation solution; and piezoelectric mesh nebulizer, electric nasal cleaner, BFS hypertonic and physiological seawater nasal cleansing fluid products under the ChangShu name. The company also develops products for the treatment of respiratory diseases, including allergic rhinitis, asthma, chronic obstructive pulmonary, respiratory infection, pulmonary fibrosis, pulmonary hypertension, and other respiratory diseases. In addition, it develops therapeutic products for respiratory and other diseases, such as inhalation spray and aerosol, dry powder inhaler, nebulization, nasal spray products, as well as liposomes. Further, the company provides CDMO/CMO technical services. CF PharmTech, Inc. was formerly known as Suzhou CF PharmTech Co., Ltd. CF PharmTech, Inc. was founded in 2007 and is based in Suzhou, China.
- ISIN
- CNE1000074R9
- Founded
- 2007
- Listed since
- Oct 8, 2025
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,226.58 | -0.57% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $271.58 | -0.57% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.68 | -1.77% |
| Roche Holding AGSWX: ROP | $371.62B | CHF369.70 | -1.10% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.92 | -1.47% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.35 | -0.77% |
Figures last refreshed Aug 18, 2026.